Navigation Links
Advanced Life Sciences Announces Third Quarter 2009 Financial Results
Date:11/10/2009

s will be issued a pin number to use when dialing into the live call which will provide quick access to the conference by bypassing the operator upon connection.

About Restanza

Restanza is a novel, once-a-day, oral antibiotic that is in late stage development for the treatment of CAP and biodefense pathogens. It has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections and appears to be effective against penicillin-, macrolide- and fluoroquinolone-resistant bacteria. Restanza's demonstrated potency and ability to overcome bacterial resistance may be due to its mechanism of action resulting in specificity for its bacterial target. In addition to its utility in CAP, Restanza is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure and other high priority biodefense pathogens, including plague and tularemia. The FDA has designated Restanza as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, as well as for use in treating plague and tularemia, but the drug is not yet approved for these or any other indications.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of respiratory tract infections including CAP and biodefense pathogens including anthrax, plague and tularemia. For more information, please visit us on the web at www.advancedlifesciences.com.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, ev
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
2. Free 2D/3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging
3. Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
4. Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System
5. Lumenis Introduces Advanced Retinal Laser Delivery Technology at the 2009 American Academy of Ophthalmology Annual Meeting in San Francisco, California, USA
6. Advanced Health Media Named to Deloittes 2009 Technology Fast 500(TM)
7. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
8. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
9. FDA Approves New Treatment for Advanced Form of Kidney Cancer
10. Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations
11. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5. März 2015  Die amerikanische Bill ... biopharmazeutische Unternehmen CureVac geben heute bekannt, dass ... US-Dollar) in CureVac investiert. CureVac ist weltweit ... (mRNA). Auf Basis dieses Moleküls entwickelt CureVac ... und zum Schutz vor Infektionskrankheiten. ...
(Date:3/5/2015)... -- CANTEL MEDICAL CORP. (NYSE: CMN ) will ... 2015 on Thursday, March 12 before the market opens, and ... AM ET. To participate in the conference ... the beginning of the call. If you are unable to ... from Thursday, March 12, 2015 through midnight on May 12, ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
...  BioMed Realty Trust, Inc. (NYSE: BMR ) ... with Depomed, Inc. (NASDAQ: DEPO ) at ... a specialty pharmaceutical company, leased approximately 60,000 square feet ... Realty,s multi-tenant Pacific Research Center campus. Commenting ...
... Fla., April 9, 2012 Med-Tek a developer of Healthcare ... physicians, employers and their constituents today announces the launch ... According to the United States Bone ... individuals suffering from musculoskeletal disease ...
Cached Medicine Technology:New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 2New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 3Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2
(Date:3/6/2015)... Many patients with knee osteoarthritis have continued pain ... someone you know) have chronic pain and problems with ... in the ACT-OA clinical trial. , Kevin Darr, ... one of fifteen physicians in the U.S. to receive ... part of a new, multi-site, double blind, placebo-controlled clinical ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 In a new ... Polish mesothelioma patients reported that shoulder pain was their first ... on its website. Click here to read it now. ... analyzed the medical records of 49 mesothelioma patients ... reported that it was shoulder pain that first prompted them ...
(Date:3/6/2015)... Los Angeles cosmetic dentist , Dr. ... whitening. Zoom is a special type of teeth whitening treatment ... teeth whitening treatments, Zoom does its job in about an ... a limited time, Dr. Ghasri is offering Zoom for just ... of $650 and allows patients to try out this revolutionary ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... to be discussed, Ford & Associates Nationwide Legal Services, ... January 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., ... of California. , “In light of a recently ... used Benicar to evaluate and explore the Mayo Clinic's ...
(Date:3/5/2015)... 05, 2015 Shania Twain will be ... a decade. She has hinted that this will be her ... her perform one last time. She has had a residency ... country sweetheart has millions of loyal fans around the world. ... country, Canada, and on June 30th she will be at Madison ...
Breaking Medicine News(10 mins):Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... fibrillation study, blood-thinning drug best for those at highest risk ... Older patients, or those with a prior history of stroke, ... to treat atrial fibrillation, a common heart rhythm disorder, a ... researchers also say the drug is especially beneficial for patients ...
... provide research model, possible treatment for type 1 diabetes in ... skin cells from people with type 1 diabetes, researchers were ... changing blood sugar levels, though not as efficiently as normal ... experiment is that scientists now have a preliminary lab model ...
... new report finds , MONDAY, Aug. 31 (HealthDay News) -- ... a pull on medical sleuths nearly 50 years after the ... Navy physician claims that Kennedy suffered from a more complex ... as a young man. , In the Sept. 1 issue ...
... get their care based on how long it takes to ... Center have recently documented a growing trend in the centralization ... which are generally located in metropolitan areas. While trends ... the Journal of Clinical Oncology shows that there ...
... Blue Cross Blue Shield of ... ... new H1N1 (swine) flu puts increased emphasis on preparing early for the upcoming flu season. The ... flu shot as soon as possible. Since both the seasonal flu and the new H1N1 (swine) ...
... , , , ... 31 Healthspottr Media LLC, a new media and publishing ... through innovation today with the launch of the Annual Healthspottr ... award qualified recipients with prizes of up to $250,000 each ...
Cached Medicine News:Health News:Oldest Heart Patients May Get Most From Warfarin 2Health News:Researchers Make Insulin-Producing Cells From Adult Skin Cells 2Health News:Researchers Make Insulin-Producing Cells From Adult Skin Cells 3Health News:JFK's Health Problems More Complex Than Thought 2Health News:JFK's Health Problems More Complex Than Thought 3Health News:Does the distance a patient has to travel affect where they choose to get their care? 2Health News:Flu Season Preparation Comes Early 2Health News:Flu Season Preparation Comes Early 3Health News:Flu Season Preparation Comes Early 4Health News:Healthspottr Launches New Fellows Program for Health Innovators 2Health News:Healthspottr Launches New Fellows Program for Health Innovators 3
Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 80 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: